ATPase H+ transporting accessory protein 2 is a multifunctional protein serving as an accessory subunit to the V-type ATPase proton pump complex and as a cellular receptor for renin and prorenin. It is central to the acidification and maintenance of endo-lysosomal pH critical for protein degradation, cell signaling, and organelle function. As the prorenin/renin receptor, it mediates intracellular signaling cascades (notably involving ERK1/2) and increases the efficiency of angiotensinogen conversion to angiotensin I, linking it to the renin-angiotensin system and blood pressure regulation. Genetic mutations and dysregulation of its function are associated with neurodevelopmental and metabolic disorders, making it both a valuable diagnostic biomarker and a potential therapeutic target.
Other names
Renin receptor (PRR)Prorenin receptorRENRATP6M8-9ATP6IP2Vacuolar ATP synthase membrane sector-associated protein M8-9ATPase, H+ transporting, lysosomal interacting protein 2ER-Localized Type I Transmembrane AdapterEmbryonic Liver Differentiation Factor 10 (ELDF10)M8-9Vacuolar proton ATP synthase membrane sector associated protein M8-9ENSEMBL: ENSG00000182220UniProt: O75787
02
Mechanism of action
Drugs would act by inhibition/activation of receptor-mediated signaling (renin/prorenin pathway)
Modulation of V-ATPase assembly and lysosomal acidification
Blockage of ERK1/2 downstream signaling
03
Biological functions
Assembly and function of the lysosomal V-type ATPase (V-ATPase)Acidification of the endo-lysosomal system (pH regulation)Protein degradationCellular pH homeostasisModulation of renin-dependent cellular signaling; activation of ERK1/2 via prorenin/renin bindingRegulation of signaling pathways critical for brain development, synapse morphology, and transmission
04
Disease associations
Parkinsonism with spasticity (X-linked)Congenital disorder of glycosylation, type IirNeurodevelopmental disordersPossible role in hypertension and organ fibrosis (via renin-angiotensin system dysregulation)
05
Safety considerations
Disruption of ATP6AP2 function may result in lysosomal dysfunction, cellular pH dysregulation, and altered protein degradation.Alteration of renin/prorenin receptor activity could impact systemic blood pressure, kidney function, and risk of neurodevelopmental or neurodegenerative disorders
06
Interacting drugs
No approved direct drugs currently, but research compounds and antibodies targeting the renin/prorenin receptor (PRR) function have been described
07
Biomarkers
Expression levels of ATP6AP2/PRR may serve as biomarkers for renin-angiotensin system activity or lysosomal function in disease, but these are not yet clinically validated
Beyond the preview
Go deeper on ATPase H+ transporting accessory protein 2 (ATP6AP2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on ATPase H+ transporting accessory protein 2 (ATP6AP2).